From the Department of Surgery (R.B., M.K.S., J.S.C., M.A.D., T.M.M., M.F., P.J.O., I.I.P., W.X., B.T.B.), Department of Pathology and Microbiology (M.A.D., B.T.B.), and Department of Biostatistics, College of Public Health (J.L.), University of Nebraska Medical Center, Omaha.
Arterioscler Thromb Vasc Biol. 2018 Feb;38(2):457-463. doi: 10.1161/ATVBAHA.117.310333. Epub 2017 Dec 7.
Abdominal aortic aneurysms are inflammatory in nature and are associated with some risk factors that also lead to atherosclerotic occlusive disease, most notably smoking. The purpose of our study was to identify differential cytokine expression in patients with abdominal aortic aneurysm and those with atherosclerotic occlusive disease. Based on this analysis, we further explored and compared the mechanism of action of IL (interleukin)-1β versus TNF-α (tumor necrosis factor-α) in abdominal aortic aneurysm formation.
IL-1β was differentially expressed in human plasma with lower levels detected in patients with abdominal aortic aneurysm compared with matched atherosclerotic controls. We further explored its mechanism of action using a murine model and cell culture. Genetic deletion of IL-1β and IL-1R did not inhibit aneurysm formation or decrease MMP (matrix metalloproteinase) expression. The effects of IL-1β deletion on M1 macrophage polarization were compared with another proinflammatory cytokine, TNF-α. Bone marrow-derived macrophages from IL-1β and TNF-α mice were polarized to an M1 phenotype. TNF-α deletion, but not IL-1β deletion, inhibited M1 macrophage polarization. Infusion of M1 polarized TNF-α macrophages inhibited aortic diameter growth; no inhibitory effect was seen in mice infused with M1 polarized IL-1β macrophages.
Although IL-1β is a proinflammatory cytokine, its effects on aneurysm formation and macrophage polarization differ from TNF-α. The differential effects of IL-1β and TNF-α inhibition are related to M1/M2 macrophage polarization and this may account for the differences in clinical efficacy of IL-1β and TNF-α antibody therapies in management of inflammatory diseases.
腹主动脉瘤在性质上是炎症性的,与一些导致动脉粥样硬化闭塞性疾病的风险因素有关,最显著的是吸烟。我们的研究目的是确定腹主动脉瘤患者和动脉粥样硬化闭塞性疾病患者之间差异表达的细胞因子。基于此分析,我们进一步探讨和比较了白细胞介素(IL)-1β与肿瘤坏死因子(TNF)-α在腹主动脉瘤形成中的作用机制。
人血浆中 IL-1β表达存在差异,与匹配的动脉粥样硬化对照组相比,腹主动脉瘤患者的水平较低。我们进一步使用小鼠模型和细胞培养来探索其作用机制。IL-1β和 IL-1R 的基因缺失并未抑制动脉瘤形成或降低 MMP(基质金属蛋白酶)表达。比较了 IL-1β缺失对 M1 巨噬细胞极化的影响与另一种促炎细胞因子 TNF-α的影响。从 IL-1β和 TNF-α 小鼠的骨髓来源巨噬细胞被极化至 M1 表型。TNF-α缺失而非 IL-1β缺失抑制 M1 巨噬细胞极化。M1 极化的 TNF-α巨噬细胞的输注抑制了主动脉直径的生长;输注 M1 极化的 IL-1β巨噬细胞则未见抑制作用。
尽管 IL-1β是一种促炎细胞因子,但它对动脉瘤形成和巨噬细胞极化的作用不同于 TNF-α。IL-1β和 TNF-α抑制的差异作用与 M1/M2 巨噬细胞极化有关,这可能解释了 IL-1β和 TNF-α抗体疗法在炎症性疾病管理中的临床疗效差异。